Weekly Semaglutide Bests Placebo for Greater Weight Loss

THURSDAY, April 1, 2021 -- Once-weekly subcutaneous semaglutide results in significantly greater weight loss than placebo when used as adjunctive therapy over 68 weeks in adults with overweight or obesity, according to a study published online Feb....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news